Vaccines against invasive Salmonella disease: current status and future directions - Wikidata - wikimedia - TriplyDB

Vaccines against invasive Salmonella disease: current status and future directions

Vaccines against invasive Salmonella disease: current status and future directions

http://www.wikidata.org/entity/Q27007088

about

Live attenuated vaccines for invasive Salmonella infections Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures Enteric fever in India: current scenario and future directions Role of T3SS-1 SipD Protein in Protecting Mice against Non-typhoidal Salmonella Typhimurium Salmonella Serogroup C: Current Status of Vaccines and Why They Are Needed Population-based incidence, seasonality and serotype distribution of invasive salmonellosis among children in Nanoro, rural Burkina Faso.Transient Loss of Protection Afforded by a Live Attenuated Non-typhoidal Salmonella Vaccine in Mice Co-infected with Malaria.Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen Combination vaccines against diarrheal diseases.Monoclonal Antibodies of a Diverse Isotype Induced by an O-Antigen Glycoconjugate Vaccine Mediate In Vitro and In Vivo Killing of African Invasive Nontyphoidal Salmonella.Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease Modeling the Potential for Vaccination to Diminish the Burden of Invasive Non-typhoidal Salmonella Disease in Young Children in Mali, West Africa.Genes Required for the Fitness of Salmonella enterica Serovar Typhimurium during Infection of Immunodeficient gp91-/- phox Mice.Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis.Building the case for wider use of typhoid vaccines.Protein-L-Isoaspartyl Methyltransferase (PIMT) Is Required for Survival of Salmonella Typhimurium at 42°C and Contributes to the Virulence in Poultry.Salmonella enterica Serovar Typhi Lipopolysaccharide O-Antigen Modification Impact on Serum Resistance and Antibody Recognition Identification of Protective Antigens for Vaccination against Systemic Salmonellosis.Antibodies and protection against invasive salmonella disease.Genetic susceptibility to invasive Salmonella disease.Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.Igg Subclasses Targeting the Flagella of Salmonella enterica Serovar Typhimurium Can Mediate Phagocytosis and Bacterial Killing.Gas-filled microbubbles: Novel mucosal antigen-delivery system for induction of anti-pathogen's immune responses in the gut.Immunology, epidemiology and mathematical modelling towards a better understanding of invasive non-typhoidal Salmonella disease and rational vaccination approaches.Animal Models for Salmonellosis: Applications in Vaccine Research Disseminated infections with antibiotic-resistant non-typhoidal Salmonella strains: contributions of host and pathogen factors.The Need for an Information Communication and Advocacy Strategy to Guide a Research Agenda to Address Burden of Invasive Nontyphoidal Salmonella Infections in Africa.Role of sapA and yfgA in Susceptibility to Antibody-Mediated Complement-Dependent Killing and Virulence of Salmonella enterica Serovar Typhimurium.Vaccination against Salmonella Infection: the Mucosal Way.Serodiagnosis of Acute Typhoid Fever in Nigerian Pediatric Cases by Detection of Serum IgA and IgG Against Hemolysin E and Lipopolysaccharide.Recombinant attenuated Salmonella Typhimurium with heterologous expression of the Salmonella Choleraesuis O-polysaccharide: high immunogenicity and protection.Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.Outer membrane vesicles derived from Salmonella Typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model.British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.Opsonophagocytic Assay To Evaluate Immunogenicity of Nontyphoidal Salmonella Vaccines.Two Novel Salmonella Bivalent Vaccines Confer Dual Protection against Two Salmonella Serovars in Mice.Purification and Anti-pathogenic Properties of Immunoglobulin Concentrates from Porcine Blood.

P2860

Q27003066-DD85E83A-BF8A-4CD6-87CA-55EC2DFDD921 Q27004488-F85C1F4E-CEAF-4193-B523-F041B5698C19 Q27011190-2EDB07F5-C9AC-4F47-87F4-55309BF05666 Q27687760-6B997314-B91B-47CB-857F-EC13E65C2C82 Q28070030-2A40092A-0849-457C-B439-5661555DDC51 Q28354066-6DA74E29-0F10-4684-BCD2-A6587617BFC6 Q28388835-6F86C6F3-CEF3-4729-B0BE-729A13268068 Q33887886-FFA64AFE-FC48-4DDF-A7AD-687CD280B1F3 Q35772279-76E94C11-3BBC-40B4-B199-9FCF44D76CB3 Q35887055-CDCB07AF-74EB-4D01-BA75-0EA201880735 Q35888059-F263189D-5D52-4538-A0CE-30084D623353 Q35896237-8178B6F5-FD02-4C96-8906-5DEE47AC91F0 Q35947429-CA6A1458-726E-4965-8F00-A92BBC80DE37 Q36131886-4E17D8AE-8C46-477B-8734-443A54C57C66 Q36275289-5C958F9F-1AD8-41CE-8814-E77E6629C09C Q36728007-677D771F-5448-4524-AEED-8A2348899338 Q36764359-498C1B7A-A015-4C1E-9B3A-DF98F694133D Q36824195-67055B7A-0985-4F14-9F32-AE187F78639E Q37683064-D5ADEF8B-1050-4FB2-A480-747A384EB538 Q37719214-D629A025-BB95-4C25-A55F-31AABA65DACD Q38243324-3A2C952A-5702-4A50-AF8B-163091BC3482 Q38310237-4A8ADE96-A74C-4026-BD58-E7A91956D1D9 Q38537340-764F1D26-5CB9-482D-89E9-F3EF05BEE01E Q38600784-3F2CB14A-0265-4FA4-BD67-EFE059C77278 Q38760495-63F93469-DF22-4742-B14C-69D0CA579D89 Q38765335-33E79884-5022-42CA-AC16-0FEBBB86977A Q38832842-37C0BFB6-212A-4C37-9168-5B71A4E1D658 Q38896014-C62DCDDE-1D18-4A4D-99C6-3E3442A0650E Q38986684-C7F6B27E-849A-457C-BCE9-243CE62082CE Q39093995-5A91C3CF-6F67-42C7-A43E-98D4117CFA7F Q39324831-7B9AC2AB-1D87-4537-973D-D7570529717C Q39373957-B1C7B94D-2454-449C-9AB2-A63544D29352 Q40104551-239FA00F-295D-4E39-9C02-23BF207133B4 Q40114957-455989D9-4279-4123-9CEB-5F74521B1EEC Q40151178-DB3F6EDB-83CA-4589-AADB-DC65662D5D92 Q40557181-42181207-DE14-4302-A795-86384F0A69FD Q40560650-416C451B-FC12-4629-B9CB-9360AA82BD16 Q40734790-27CA909C-CBC4-47E0-BA04-6DAD947C770F Q41475755-FFB88C76-0683-4C3F-A7F7-4C50A7C9264A Q46215190-88CDB689-CE1C-485A-971A-5C7627AC5A16

P2860

Vaccines against invasive Salmonella disease: current status and future directions

http://www.wikidata.org/entity/Q27007088

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Vaccines against invasive Salmonella disease: current status and future directions

@ast

Vaccines against invasive Salmonella disease: current status and future directions

@en

Vaccines against invasive Salmonella disease: current status and future directions

@nl

type

label

Vaccines against invasive Salmonella disease: current status and future directions

@ast

Vaccines against invasive Salmonella disease: current status and future directions

@en

Vaccines against invasive Salmonella disease: current status and future directions

@nl

prefLabel

Vaccines against invasive Salmonella disease: current status and future directions

@ast

Vaccines against invasive Salmonella disease: current status and future directions

@en

Vaccines against invasive Salmonella disease: current status and future directions

@nl

P1433

Q27007088-C863C101-F0F4-4FB2-B753-DAD40FDC8BA3

P1476

Q27007088-C726B0B9-4C59-460A-AA69-4BECEC45F9E3

P2093

Q27007088-D05C1B47-3E9D-48FE-BD49-7C193576A57F

Q27007088-DC27DB4F-10E9-4C5A-AF3B-95308CFEFA4F

P275

Q27007088-669C43AE-5D1F-4612-ABB3-85D8E48D2553

P2860

Q27007088-00F48AB8-653D-49B5-933B-B8578CE59959

Q27007088-013E4198-5B6E-4266-9BDC-0CC13670459E

Q27007088-0200ACE7-6B6F-4DC9-B406-57622F9691B8

Q27007088-0271314A-67B4-4727-A4C2-E2EEC3E0CA56

Q27007088-02C7FDCA-604F-4E61-B349-465E7D2840BB

Q27007088-06C27272-C2C3-476C-B054-90950FCD5CD1

Q27007088-06CD511F-D152-4580-88DF-B2C60DCF478B

Q27007088-07929B9B-45AF-4674-814E-4DAB28F894BB

Q27007088-0879671B-0AF1-40CA-859F-D1D74E859E58

Q27007088-09C87D3E-441C-4734-8960-29BE27BDED63

P304

Q27007088-60CCB4A1-FBAF-417A-9884-EF46AADB6A77

P31

Q27007088-361D33FF-B8EC-4D76-BD45-462C21F89FC2

Q27007088-7DA9A32B-06DC-4264-83C8-FAD54C675B7E

P356

Q27007088-0B18AEA7-54D2-4CB3-AB46-AAEEF261B87F

P407

Q27007088-90B276D0-F1AC-41D2-BA30-97C17E315201

P433

Q27007088-91B14BBE-030B-4F3B-AC4A-B91A4B3D2F29

P478

Q27007088-3F78B6D1-CD1E-47FF-9B84-0BCEEE28BACD

P50

Q27007088-D0FD921F-18AF-4FCF-AC5C-C90645F3E18F

P5008

Q27007088-8A570BE7-CC47-4E9B-82B0-54D50B5E9B0A

P577

Q27007088-3CD7BE2D-9CA4-401B-B352-86C1A3AE4448

Q27007088-704316B9-DFB4-484D-A776-9D869B899B15

P698

Q27007088-1A501F51-0977-49EA-846A-E8AA460261D4

P921

Q27007088-BB31B6B6-8D69-4E44-8041-6042AE69592C

P932

Q27007088-F4714C60-D94F-4C2E-8077-534BFE4C8D13

P356

P1433

Human Vaccines & Immunotherapeutics

P1476

Vaccines against invasive Salmonella disease: current status and future directions

@en

P2093

Francesca Micoli

http://www.w3.org/2001/XMLSchema#string

Laura B Martin

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 3.0 Unported

P2860

The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children

Vaccines for low-income countries

Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B

Role of monoclonal O-antigen antibody epitope specificity and isotype in protection against experimental mouse typhoid

A randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy Vietnamese children

Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa

Differing burden and epidemiology of non-Typhi Salmonella bacteremia in rural and urban Kenya, 2006-2009

High yield production process for Shigella outer membrane particles

Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults

The global burden of typhoid fever

P304

1478-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.29054

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Calman A MacLennan

P5008

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2014-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24804797

http://www.w3.org/2001/XMLSchema#string

P921

P932

4185946

http://www.w3.org/2001/XMLSchema#string